Company Profile
Updated: 24-MAR-09Evotec AG
International public company
Schnackenburgallee 114, Hamburg, D-22525, Germany
()49 040 5 60 81 0, 49 040 5 60 81 222 fax, http://www.evotec.com
Primary SIC: Laboratory Analytical Instruments, Primary NAICS: Analytical Laboratory Instrument Manufacturing
Description: Manufacturing: Evotec OAI AG is a biotechnology company serving the life science industry by designing and applying technologies for highly effective drug discovery. Evotec offers products and services which are designed to increase the speed, accuracy and efficiency of the drug discovery process and designs and develops systems for the efficient screening of a large number of chemical compounds (ultra-high-throughput screening)
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
www.Xtremepicks.Com: Xtremepicks Alerts November 6, 2009 : NTES, ALNC, INSM and EVTC.
M2 Presswire; 11/6/2009; 1541 words; ...Insmed Inc. (Nasdaq: INSM) and Evotec AG (Frankfurt:EVT) (Nasdaq: EVTC...visit http://www.insmed.com. Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC...HAMBURG, Germany, Nov 6, 2009 -- Evotec AG (Frankfurt:EVT) (TecDAX...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2541 words; ...ongoing Phase II trial to treat fibromyalgia syndrome. Evotec OAI AG, of Hamburg, Germany, granted a license to Roche Diagnostics...investigated gene fragments on polymerase chain reactions. Evotec said its technology in instrumentation and kits are designed...
U3 Pharma Raises [euro]27M For Preclinical Cancer Products.
BIOWORLD Today; 11/3/2009; 926 words; BioWorld International Correspondent U3 Pharma AG raised C27 million (US$34.7 million) to accelerate...new CEO. Henco is co-founder and previously was CEO of Evotec AG, of Hamburg, Germany, and Qiagen NV, of Venlo, the...
Optimistic Neurocrine Resubmits NDA For Insomnia Drug Indiplon.
BIOWORLD Today; 11/3/2009; 1256 words; ...aventis Group) also targets a specific area of the GABA receptor, as does a Phase II insomnia drug from Neurogen Corp. Evotec AG also has a Phase II GABA modulator in development. Reames said the main difference between the various GABA drugs is...
Evotec Halts Development Of EVT.301 In Alzheimer's.
BIOWORLD Today; 11/3/2009; 792 words; ...International Correspondent Evotec AG discontinued development...cannot explain," said Evotec CEO Joern Aldag. "These...Institutional Services AG. EVT.301 was the compound with the highest risk in Evotec's clinical portfolio...
Recent News Articles
- News and FDA Updates for MediciNova (Nasdaq:MNOV), Evotec AG (Nasdaq:EVTC), Capstone Therapeutics (Nasdaq:CAPS), and Immunomedics, Inc. (Nasdaq:IMMU).
M2 Presswire - July 15, 2009 - Evotec buys Sumit Zebrafish operations.(Evotec OAI AG)(Summit Corp)(Brief article)
Pharma Marketletter - May 18, 2009 - Q4 2008 Evotec AG Earnings Conference Call - Final.(Broadcast transcript)
Fair Disclosure Wire - March 27, 2009 - Evotec AG-Detailed Product Pipeline.
M2 Presswire - March 15, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
%20laboratory%20analytical%20instruments%20analytical%20laboratory%20instrument%20manufacturing%20%20&custom5=%20%20&position=1)